Kimberg D V, Baerg R D, Gershon E, Graudusius R T
J Clin Invest. 1971 Jun;50(6):1309-21. doi: 10.1172/JCI106610.
It is generally recognized that glucocorticoid administration may diminish calcium absorption in vivo as well as the active transport of calcium by the intestine in vitro. Recent studies by others have emphasized the possibility of an alteration in the metabolism of vitamin D to 25-hydroxycholecalciferol in accounting for the steroid effects on calcium absorption. The results obtained in the present studies fail to support this hypothesis. The present studies confirm that the administration of cortisone or other glucocorticoids to the rat interferes with the active transport of calcium by duodenal gut sacs in vitro. This abnormality is not due to an alteration in the permeability of the intestine to calcium, and it cannot be corrected by the administration of either massive doses of vitamin D(2) or modest doses of 25-hydroxycholecalciferol. Experiments concerned with the effects of cortisone on the level of the vitamin D-dependent duodenal calcium-binding protein, the amount of bioassayable vitamin D activity in the mucosa, and the distribution and metabolism of (3)H-vitamin D(3), did not provide evidence in favor of a harmone-related defect in either the localization of vitamin D or its metabolism to 25-hydroxycholecalciferol. Alterations in the transport of iron and D-galactose, not dependent on vitamin D, suggest that cortisone treatment may be responsible for more than a simple antagonism to the effects of vitamin D. The results of the present studies indicate that cortisone administration affects the cellular mechanisms mediating calcium transport in a manner that is opposite to the effects of vitamin D, but seems to be independent of any direct interaction with the parent vitamin or its metabolites. If a disorder in vitamin D metabolism is at all involved, it is at a step subsequent to 25-hydroxylation.
人们普遍认为,体内给予糖皮质激素可能会减少钙的吸收,以及体外肠道对钙的主动转运。其他人最近的研究强调,维生素D代谢为25-羟胆钙化醇的改变可能是类固醇对钙吸收产生影响的原因。本研究获得的结果未能支持这一假设。本研究证实,给大鼠注射可的松或其他糖皮质激素会干扰体外十二指肠肠囊对钙的主动转运。这种异常并非由于肠道对钙的通透性改变所致,而且大剂量维生素D2或中等剂量的25-羟胆钙化醇给药均无法纠正。关于可的松对维生素D依赖性十二指肠钙结合蛋白水平、黏膜中可生物测定的维生素D活性量以及3H-维生素D3的分布和代谢的影响的实验,并未提供证据支持维生素D的定位或其代谢为25-羟胆钙化醇存在与激素相关的缺陷。铁和D-半乳糖的转运改变不依赖于维生素D,这表明可的松治疗可能不仅仅是对维生素D的作用产生简单的拮抗作用。本研究结果表明,可的松给药以与维生素D相反的方式影响介导钙转运的细胞机制,但似乎与母体维生素或其代谢产物没有任何直接相互作用。如果维生素D代谢紊乱确实涉及其中,那也是在25-羟化之后的步骤。